tiprankstipranks
Advertisement

SASS - ETF AI Analysis

Compare

Top Page

SASS

M.D. Sass Concentrated Value ETF (SASS)

Rating:68Neutral
Price Target:
SASS (M.D. Sass Concentrated Value ETF) earns a solid overall rating, mainly driven by strong, high-quality holdings like Intercontinental Exchange, Ametek, and Quest Diagnostics, which show robust financial performance, positive earnings calls, and generally supportive technical trends. Amazon, Clean Harbors, and Capital One also add strength through growth and strategic initiatives, though their higher valuations and some short-term technical or economic uncertainties introduce caution. Weaker names like Primo Brands, which faces profitability and technical pressures despite some revenue growth, slightly weigh on the fund, and investors should note that the ETF is relatively concentrated in a limited number of holdings, which can increase risk if any one position struggles.
Positive Factors
Strong Recent Monthly Performance
The ETF has shown a solid gain over the past month, suggesting improving short-term momentum.
Several Strong Top Holdings
Many of the largest positions, including companies like Ametek, Amazon, Primo Brands, Clean Harbors, and Williams, have delivered strong year-to-date gains that support the fund’s results.
Diversified Sector Exposure
Holdings spread across industrials, health care, financials, consumer sectors, energy, real estate, materials, and technology help reduce reliance on any single industry.
Negative Factors
Negative Year-to-Date Performance
The ETF is down so far this year, indicating that it has lagged despite some strong individual holdings.
High Expense Ratio
The fund charges relatively high fees for an ETF, which can eat into long-term returns for investors.
Concentrated and U.S.-Heavy Portfolio
A focus on a limited number of stocks and heavy exposure to U.S. companies increases the impact of stock-specific and domestic market risks.

SASS vs. SPDR S&P 500 ETF (SPY)

SASS Summary

The M.D. Sass Concentrated Value ETF (SASS) is an actively managed fund that focuses on U.S. mid- and large-sized companies the managers believe are undervalued. It doesn’t track a set index, but instead picks a small group of stocks across many sectors, including industrials, health care, and financials. Well-known holdings include Amazon and Capital One Financial. Someone might invest in SASS to seek long-term growth and dividends from value stocks while adding diversification beyond pure tech or growth funds. A key risk is that the fund is concentrated, so a few poorly performing stocks can significantly hurt returns and it can go up and down with the stock market.
How much will it cost me?This ETF has an expense ratio of 0.75%, which means you’ll pay about $7.50 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, paying a professional team to research and select a smaller group of value stocks they believe can outperform the market.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, industrial and health care companies grow profits, and investors favor value stocks, which may help its concentrated bets in names like Ametek, Henry Schein, and Amazon. On the other hand, a U.S. slowdown, rising interest rates hurting financials and real estate, or poor performance from a few large holdings could weigh heavily on returns because the fund is focused in specific sectors and a relatively small number of stocks.

SASS Top 10 Holdings

SASS lives up to its “concentrated value” label, with a tight roster of U.S. names where a few standouts are doing the heavy lifting. Industrial players like Ametek and Clean Harbors are rising and act as key engines for the fund, while Amazon adds a dash of Big Tech momentum despite its premium price tag. Health care names such as Henry Schein and Quest Diagnostics are steady contributors. On the flip side, Capital One and Martin Marietta are lagging, occasionally putting a brake on performance in this otherwise industrial‑tilted, U.S.-focused portfolio.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Henry Schein7.22%$5.35M$8.90B17.74%
74
Outperform
Ametek6.37%$4.72M$53.36B40.10%
79
Outperform
Williams Co6.14%$4.54M$88.27B20.03%
76
Outperform
Primo Brands5.68%$4.21M$7.41B-37.12%
57
Neutral
Amazon5.44%$4.03M$2.84T39.12%
71
Outperform
Clean Harbors5.11%$3.79M$16.47B44.54%
78
Outperform
Quest Diagnostics5.11%$3.78M$21.73B11.29%
79
Outperform
Capital One Financial4.99%$3.70M$118.48B6.00%
71
Outperform
Martin Marietta Materials4.97%$3.68M$37.08B21.25%
73
Outperform
Intercontinental Exchange4.78%$3.54M$89.75B-3.99%
80
Outperform

SASS Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
100DMA
200DMA
Market Momentum
MACD
0.26
Negative
RSI
52.76
Neutral
STOCH
20.23
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SASS, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 24.26, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.26 indicates Negative momentum. The RSI at 52.76 is Neutral, neither overbought nor oversold. The STOCH value of 20.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SASS.

SASS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$74.79M0.75%
68
Neutral
$99.90M0.91%
74
Outperform
$84.28M0.50%
73
Outperform
$59.01M0.30%
67
Neutral
$39.24M0.45%
73
Outperform
$39.05M0.87%
57
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SASS
M.D. Sass Concentrated Value ETF
24.52
-0.17
-0.69%
BAMV
Brookstone Value Stock ETF
GMOV
GMO US Value ETF
VUSV
Vanguard Wellington U.S. Value Active ETF
GVLE
Goldman Sachs Value Opportunities ETF
CVAR
Cultivar ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement